CME Group CFO says to discuss whether to move dividend foward CFO says board will discuss next month whether to move dividend forward. Comments made at the KBW Securities Brokerage & Market Structure Conference.
CME Group price target raised to $92 from $84 at Argus Argus increased its price target on CME as the firm expects the company's results to improve in coming quarters. The firm predicts that the company will benefit from renewed demand for risk management products, and anticipates that it will keep its costs in check. Argus keeps a Buy rating on the shares.